DEAL: Medday raises €34 million

The French Startup MEDDAY, specialized in the treatment of neuro-metabolic diseases, received 34 million euros in second funding to start commercialisation in the US.

This 34 million euros round was led by Edmond de Rothschild Investment Partners, Sofinnova Partners, InnoBio, Large Venture.

EXPEN is advisor to the transaction.